Insight

Apr 9, 2024, 09:03

Giannis Mountzios: The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC

Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital in Athens, shared a post on X:

“The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC.

Very elegant work in the New England Journal of Medicine by Benjamin Besse and colleagues exemplifying the value of post-marketing pragmatic re-assessment of new TKIs in NSCLC. Be aware!”

View the additional information.
Source: Giannis Mountzios/X

Air force General Hospital in Athens Benjamin Besse cancer Giannis Mountzios New England Journal of Medicine non small cell lung cancer NSCLC OncoDaily Oncology Selpercatinib TKIs

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage